相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
Pan Li et al.
CANCER LETTERS (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy
Alvaro Teijeira et al.
CLINICAL CANCER RESEARCH (2021)
Tumor-associated macrophages in immunotherapy
Shijia Yan et al.
FEBS JOURNAL (2021)
Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
Jingwei Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Uncoupled biological and chronological aging of neutrophils in cancer promotes tumor progression
Laura A. Mittmann et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy
Liangliang Wu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies
Nina B. Horowitz et al.
FRONTIERS IN IMMUNOLOGY (2021)
Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
Ruiyu Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer
Carmine Carbone et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan-Tong Liu et al.
THERANOSTICS (2021)
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer
Raffaela Santoro et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Patient-derived xenograft models-the future of personalised cancer treatment
Jenna Bhimani et al.
BRITISH JOURNAL OF CANCER (2020)
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy
Wai Nam Liu et al.
CANCERS (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
IL-8 and cancer prognosis on immunotherapy
Ziad Bakouny et al.
NATURE MEDICINE (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C. Yuen et al.
NATURE MEDICINE (2020)
Innovations, challenges, and minimal information for standardization of humanized mice
Renata Stripecke et al.
EMBO MOLECULAR MEDICINE (2020)
A Neutrophil Timer Coordinates Immune Defense and Vascular Protection
Jose M. Adrover et al.
IMMUNITY (2019)
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
Eva Karamitopoulou
BRITISH JOURNAL OF CANCER (2019)
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial
Eileen M. O'Reilly et al.
JAMA ONCOLOGY (2019)
Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
Diletta Di Mitri et al.
CELL REPORTS (2019)
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
Dea Filippini et al.
SCIENTIFIC REPORTS (2019)
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Xiaomeng Liu et al.
MOLECULAR CANCER (2019)
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity
Raffaela Santoro et al.
ANTICANCER RESEARCH (2018)
Pancreatic Ductal Adenocarcinoma: A Strong imbalance of Good and Bad immunological Cops in the Tumor Microenvironment
Etienne D. Foucher et al.
FRONTIERS IN IMMUNOLOGY (2018)
Humanized Mice for the Study of Immuno-Oncology
Philippe De La Rochere et al.
TRENDS IN IMMUNOLOGY (2018)
Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo
Davalyn Powell et al.
SCIENTIFIC REPORTS (2018)
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
Tim D. D. Somerville et al.
CELL REPORTS (2018)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
Daria Marley Kemp et al.
ONCOTARGET (2017)
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
Andrea Facciabene et al.
ONCOIMMUNOLOGY (2017)
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
Lucy Ireland et al.
CANCER RESEARCH (2016)
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Carlos Alfaro et al.
CLINICAL CANCER RESEARCH (2016)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma
Timothy Chao et al.
CANCER IMMUNOLOGY RESEARCH (2016)
HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act
Andrea A. Zachary et al.
FRONTIERS IN IMMUNOLOGY (2016)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor
R. Bertini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events
Mieke Gouwy et al.
MOLECULAR PHARMACOLOGY (2008)
Humanized mice in translational biomedical research
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes
R Bonecchi et al.
JOURNAL OF IMMUNOLOGY (2000)